328 fundamentals
Key facts
Market capitalization—
Founded—
CEO—
Website—
About
MeiraGTx Holdings Plc engages in the development of novel gene therapy treatments. It focuses on the development and manufacturing of genetic medicines to treat both inherited and more common conditions with severe unmet need. The company was founded on March 20, 2015 and is headquartered in New York, NY.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
Dividends
Dividend yield, history and sustainability
No dividends
328 has never paid dividends and has no current plans to do so.
Financial health
Financial position and solvency of the company